Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: J Gerontol Nurs. 2021 Jul 1;47(7):6–15. doi: 10.3928/00989134-20210610-02

Table 3.

Call to action

Safety and efficacy trials on CBD use of pain management are needed for older adult and ethnic and racial minority populations.
Package labelling of CBD products needs to be accurate and enforced across the nation.
Uniformity in CBD ingredients and dosing across states.
Clinicians must be cognizant of the contents of the products they recommend.